Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific

Xenotransplantation

Volumn 7, Issue 1, 2000, Pages 48-57

  Chong, Anita S F ^a   Ma, Lian Li ^a   Yin, Dengping ^a   Blinder, Leonard ^a   Shen, Jikun ^a   Williams, James W ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Accommodation; Hamster; Humoral responses; Rat; T independent; Tolerance; Xeno antibodies; Xenotransplantation

Indexed keywords

ANTIBODY; ANTIGEN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; TISSUE SPECIFICITY; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, HETEROPHILE; ANTIGENS, T-INDEPENDENT; CRICETINAE; CYCLOSPORINE; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MESOCRICETUS; MICE; MICE, INBRED BALB C; ORGAN SPECIFICITY; PANCREAS TRANSPLANTATION; RATS; RATS, INBRED LEW; SKIN TRANSPLANTATION; SPECIES SPECIFICITY; SPLEEN; TRANSPLANTATION, HETEROLOGOUS;

EID: 1642633576     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2000.00037.x     Document Type: Article

References (31)

1. PARKER W, SAADI S, LIN S, HOLZKNECHT E, BUSTOS M, PLATT J. Transplantation of discordant xenografts: a challenge revisited. Immunol Today 1996; 17: 373.
2. BACH F, WINKLER H, FERRAN C, HANCOCK W, ROBSON S. Delayed xenograft rejection. Immunol Today 1996; 17: 379.
3. LIN S, WEIDNER B, BYRNE G et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998; 101: 1745.
4. SCHMOECKEL M, BHATTI F, FAIDI A, et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 1998; 65: 1570.
5. WATERWORTH P, WATERWORTH P, DUNNING J, et al. Life supporting pig-to-baboon heart xenotransplantation. J Heart Lung Transplant 1998; 17: 1201.
6. LIN Y, SOBIS H, VANDEPUTTE M, WAER M. Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine. Transpl Proc 1994; 26: 3202.
7. LIN Y, SOBIS H, VANDEPUTTE M, WAER M. Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone. Transpl Proc 1994; 26: 3052.
8. LUCIEN J, MARATH A, RAYAT G, THLIVERIS J, KOSHAL A, YATSCOFF R. Efficacy of leflunomide to reduce xenoantibody titers in vivo: an evaluation of the prolongation of discordant xenograft survival. Transpl Proc 1996; 28: 704.
9. ULRICHS K, KAITSCHICK J, BARTLETT R, MULLERRUCHHOLTZ W. Suppression of natural xenophile antibodies with the novel immunomodulating drug leflunomide. Transpl Proc 1992; 24: 718.
10. XIAO F, CHONG A, FOSTER PF, et al. Leflunomide controls rejection in hamster to rat cardiac xenografts. Transplantation 1994; 58: 828.
11. YIN D-P, CHONG AS-F, WILLIAMS JW, et al. FK506 treatment in combination with leflunomide in hamster to rat heart and liver xenograft transplantation. Transplantation 1997; 66: 832.
12. MORRIS R, JUANG X, GREGORY C, BILLINGHAM M, ROWAN R, SHORTHOUSE R, BERRY G. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis. Transpl Proc 1995; 27: 2068.
13. CHONG AS-F, MA LL, SHEN J, BLINDER L, YIN D, WILLIAMS J. Modification of humoral responses in Lewis rats to hamster heart xenografts by the combination of leflunomide and cyclosporine. Transplantation, 1997; 64: 1650.
14. YIN D, MA L, BLINDER L, SHEN J, SANKARY H, WILLIAMS J, CHONG A-F. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model. J Immunol 1998; 161: 2044.
15. LIN Y, VANDEPUTTE M, WAER M. Effect of leflunomide on T-independent xenoantibody formation in rats receiving hamster heart xenografts. Transpl Proc 1996; 28: 952.
16. LIN Y, VANDEPUTTE M, WAER M. Mechanisms involved in long-term hamster-to-rat cardiac xenograft survival. Transpl Proc 1996; 28: 683.
17. LIN Y, VANDEPUTTE M, WAER M. Leflunomide-mediated tolerance of B lymphocytes for T-independent xenoantigens needs the presence of these xenoantigens. Transpl Proc 1997; 29: 1304.
18. LIN Y, GOEBELS J, XIA G, PING J, VANDEPUTTE M, WAER M. Induction of specific transplantation tolerance across xenogeneic barriers in the T-independent immune compartment. Nature Med 1998; 4: 173.
19. LIN Y, VANDEPUTTE M, WAER M. Suppression of T-independent IgM xenoantibody formation by leflunomide during xenografting of hamster hearts in rats. Transplantation 1998; 65: 332.
20. ONO K, LINDSEY ES. Improved technique of heart transplantation in rats. J Thoracic Cardiovasc Surg 1969; 57: 225.
21. LEE S. An improved technique of renal transplantation in rat. Surgery 1967; 61: 771.
22. SUGARBAKER P, CHANG A. Uncovered skin grafts in mice. J Immunol Methods 1979; 31: 167.
23. CHONG AS-F, SHEN J, XIAO F, BLINDER L, LIU W, SANKARY H, FOSTER P, WILLIAMS JW. Delayed xenograft rejection in the concordant hamster heart into Lewis rat model. Transplantation 1996; 62: 90.
24. PIERSON RN, WINN HJ, RUSSEL PS, AUCHINCLOSS H. Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J Exp Med 1989; 170: 991.
25. MOSES RD, AUCHINCLOSS H. Mechanisms of cellular xenograft rejection. In: COOPER DKC, KEMP E, REEMTSMA K, WHITE DJG, eds. Xenotransplantation. Berlin, Heidelberg, New York: Springer-Verlag, 1991, 101.
26. SHEN J, SHORT J, BLINDER L, KARADEMIR S, FOSTER P, SANKARY H, WILLIAMS J, CHONG A. Quantification of the changes in splenic architecture during the rejection of cardiac allografts or xenografts. Transplantation 1997; 64: 448.
27. LIN Y, VANDEPUTTE M, WAER M. Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts. J Immunol 1998; 160: 369.
28. LIN Y, SOBIS H, VANDEPUTTE M, WAER M. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model. Transpl Proc 1995; 27: 305.
29. WU G, CRAMER D, CHAPMAN F, WANG H, HREHA G, ULKER N, MAKOWKA L. Cardiac hyperacute rejection in concordant xenograft combinations induced by immunization. Transpl Proc 1992; 24: 691.
30. BACHMANN M, ZINKERNAGEL R. Neutralizing antiviral B cell responses. Annu Rev Immunol 1997; 15: 235.
31. EHL S, AICHELE P, RAMSEIER H, BARCHET W, HOMBACH J, PIRCHER H, HENGARTNER H, ZINKERNAGE LR. Antigen persistance and time of of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection. Nature Med 1998; 4: 3812.